Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease (smartGUIDE)
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 63
- 试验地点
- 2
- 主要终点
- Medication adherence
研究概览
简要总结
This study evaluates a smartphone-based cardiac rehabilitation program in adults with coronary artery disease. Half of patients will participate in a smartphone-based cardiac rehabilitation program while the other half will receive standard-of-care.
详细描述
Cardiac rehabilitation as a means to improve lifestyle-based risk factor modification, remains poorly prescribed and utilized, often due to the lack of access to programs, poor insurance coverage, cost, or patient or physician motivational factors. Low-cost solutions that can improve patient adherence to medications, risk factor reduction, and exercise could improve cardiovascular outcomes and cost-effectiveness compared to current care models.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
smartphone-based cardiac rehabilitation
The BrightHeart® mobile application is installed on the smartphone and a heart coach set up and guides the participant through a cardiac care program.
干预措施: BrightHeart® (Other)
Control
Standard-of-care alone.
结局指标
主要结局
Medication adherence
时间窗: Baseline through End of Study visit - approximately 90 days per participant.
The proportion of days coverd (PDC) expressed as a percentage but considered as a continuous variable of the composite of the prescribed P2Y12 receptor antagonist and/or the statin.
次要结局
- Medication adherence III(Baseline through End of Study visit - approximately 90 days per participant.)
- Cardiovascular risk factors VI(Baseline through End of Study visit - approximately 90 days per participant.)
- Medication adherence II(Baseline through End of Study visit - approximately 90 days per participant.)
- Cardiovascular risk factors I(Baseline through End of Study visit - approximately 90 days per participant.)
- Cardiovascular risk factors II(Baseline through End of Study visit - approximately 90 days per participant.)
- Cardiovascular risk factors III(Baseline through End of Study visit - approximately 90 days per participant.)
- Exploratory I: Rehospitalization(Baseline through End of Study visit - approximately 90 days per participant.)
- Medication adherence IV(Baseline through End of Study visit - approximately 90 days per participant.)
- Medication persistence(Baseline through End of Study visit - approximately 90 days per participant.)
- Medication adherence V(Baseline through End of Study visit - approximately 90 days per participant.)
- Cardiovascular risk factors IV(Baseline through End of Study visit - approximately 90 days per participant.)
- Cardiovascular risk factors V(Baseline through End of Study visit - approximately 90 days per participant.)
- Cardiovascular risk factors VII(Baseline through End of Study visit - approximately 90 days per participant.)
- Exploratory II: Cardiovascular outcomes(Baseline through End of Study visit - approximately 90 days per participant.)
研究者
Mintu Turakhia
Associate Professor of Cardiovascular Medicine
Stanford University